New trial aims to fix low Follow-Up rates in lung cancer screening

NCT ID NCT06324110

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial tests whether adding care coordination services—like patient navigation and direct communication—can improve how often people get the recommended follow-up after a lung cancer screening. It involves over 6,700 participants across community clinics. The goal is to see if system-level support can boost adherence and ultimately reduce lung cancer deaths.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Patient navigation and care coordination services
What this could lead to
If successful, this could show that system-level support helps more people complete lung cancer screening follow-ups, potentially reducing lung cancer deaths.
What could go wrong
This is a behavioral intervention trial, not a drug or cure. Results depend on real-world implementation and may vary across sites or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fred Hutch/University of Washington Cancer Consortium

    Seattle, Washington, 98109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.